A United Kingdom supplier, with 13 awarded contracts, totalling £384.4m, most recently 4 months ago.
This contract involves the supply of a pharmaceutical product containing kargluminic acid for the Institute "CZMP". The total value of the contract is €816,200. The procurement is aimed at enhancing health services by providing essential medicinal products. Suppliers interested in this opportunity c
This contract involves the supply of pharmaceutical products for a healthcare facility. It includes three main tasks: 1) Supply of 20 packages for Drug Programs, 2) Supply of 1 package for Chemotherapy, and 3) Supply of 1 package for General Hospital Medications. The total value of the contract is a
This contract involves the procurement and ongoing delivery of pharmaceutical products for drug programs and chemotherapy. The total value of the contract is approximately €47,077,429.62. The buyer is the National Medical Institute of the Ministry of Internal Affairs and Administration in Poland. Su
This contract involves the ongoing supply of pharmaceutical products and medical oxygen to the Clinical Hospital of Dr. J. Babiński in Krakow. Suppliers can bid on the entire contract or specific packages, which include various medications and medical food. Each bid must include details about the re
This contract involves the supply of pharmaceutical products to the Krakow University Hospital. Suppliers are required to refer to Annex 1a of the procurement documents for a detailed description of the goods needed, including a pricing sheet. This description should be read in conjunction with any
This contract involves the supply of immunosuppressive drugs. The buyer, the Independent Public Healthcare Team in Brzesko, is seeking suppliers to provide these essential medications. The total value of the contract is approximately €12,120,870.98. Interested suppliers can find more details and app
This contract involves the supply of medicinal products. Detailed specifications of the required products can be found in Annex 2 of the procurement documents.
This contract involves the procurement and ongoing delivery of immunoglobulin products for health programs. The total value of the contract is approximately €33,513,467.17. The buyer is the National Medical Institute of the Ministry of Internal Affairs and Administration in Poland. Suppliers are inv
This contract involves the supply of the medication Burosumab as part of a treatment program for patients with X-Linked Hypophosphatemia (XLH), classified under ICD-10 code E.83.3. The contracting authority does not allow partial bids, meaning the contract cannot be divided into smaller parts. Addit
This procurement opportunity involves the supply of specific medications for the treatment of cystic fibrosis. The required products include: 1. Ivacaftor 60 mg + Tezacaftor 40 mg + Elexacaftor 80 mg in 28 sachets - 20 packages 2. Ivacaftor 75 mg + Tezacaftor 50 mg + Elexacaftor 100 mg in 28 sachets
